Inno-Xmart: China's First NiTi Braided Venous Stent System for Iliofemoral Vein Obstruction – Jointly Presented by InnoLink Medical and Zhongtian Medical

According to experts at home and abroad, about 25% of people globally are at risk of iliac vein stenosis. Severe iliac vein stenosis or occlusion can lead to obstruction of venous reflux in the lower limbs, which, if not treated effectively, will seriously affect patients' quality of life. However, there are very few stents available on the market for treating venous stenosis. Arterial stents are often used as substitutes during interventional surgeries, but their off-label use carries a risk of postoperative complications.

Innomed's venous stent system boasts superior quality and technical advantages.The Inno-Xmart venous stent system developed by Innomed is mainly used in the iliac and femoral veins to treat symptomatic venous obstruction.。

Inno-Xmart Venous Stent System isThe First in ChinaObtained Class III Medical Device Registration CertificateNickel-Titanium Alloy Braided Iliac Vein Stent，Completed193 Clinical Trials，Follow-up patency rate as high as 96.07%，Clinical manifestationsSuperior to internationally marketed products。

At 19:30 on December 21 (Thursday), the 40th session of VCBeat's New Product Review is honored to inviteChen Hua, Overseas Sales Director of Innomed、Chen Chong, Director and Sales & Marketing Director of Zenith Vascular、Innomed Senior Product Manager Gao ChaoIntroducing the Inno-Xmart Venous Stent System.

 Product Structure Composition: Two parts, [Self-expanding Nitinol Braided Stent] and [Delivery System].

Delivery System: Outer Tube Diameter 10Fr, Effective Length 83cm

Closed-loop + Wide-mouth

·  Braided Self-Expanding Stent, by12 nickel-titanium alloy wiresSeamless knitting composition.

·  No broken wire ends are exposed at both ends of the stent, making the stent form an integral ""Closed-loop"Structure, able to provide betterRadial Support Force。

·  The two ends of the stent are designed to have a length of 4.5mm "Wide Mouth", which is 2mm larger in diameter than the stent body, canIncrease the anchoring of stent ends within the vessel to reduce displacement. 。

·  Three product specifications adapt to different anatomical structures., providing clinical with diverse options

1——Flush Port (Inner Tube);

2——Flushing Port (Inner and Outer Tubes);

3——Handwheel;

4——Outer Sheath;

5——Tip head;

6——Self-expanding stent;

7——Distal marker;

8——Proximal radiopaque marker;

9——Stent retractable imaging marker;

10——Safety Knob

This product is intended for use in the iliac and femoral veins and is suitable for venous obstruction diseases.

1. A closed, large-diameter nitinol wire seamlessly woven bionic stent with excellent flexibility and perfect mechanical safety.

2. For iliac veins, three types of stent designs can meet different clinical needs.

3. Patented protective delivery system ensures accurate stent positioning and uniform release.

Scan the QR code on the poster to add the assistant and schedule a live broadcast!

Chen Hua

Innomed Medical Market Director & Overseas Sales Director

University of Electronic Science and Technology of China, Master's Degree

Innomed Overseas Sales Director

Sales Director of MEA-CIS (Middle East/Africa/Russian-speaking regions) at Shanghai MicroPort Medical (Group) Co., Ltd.; National Representative of Iran at Sany Heavy Industry Co., Ltd.; Possesses extensive frontline sales and department management experience, familiar with international trade knowledge and processes, with 10 years of international trade experience and 6 years of overseas residency experience.

Chen Chong

Zenith Vascular Director and Sales & Marketing Director

Shanghai Jiao Tong University, EMBA

Director and Sales & Marketing Director of Zenith Vascular

Hongyi Medical East Region Manager

Gore Medical East Greater China Area Manager

Boston Scientific Peripheral Division Sales Manager

MicroVention, Sales Manager of National Distributor in China

15+ years of experience in vascular intervention sales and marketing

Gao Chao

Innomed Senior Product Manager

Innomed Senior Product Manager

Becton Dickinson Medical Northeast Regional Manager

With more than 7 years of experience in the medical industry, familiar with peripheral implantation and interventional devices, and having a comprehensive understanding of equipment across various departments.

Innomed, established in 2013 and led by Dr. Gong Xiaoyan, an expert introduced through the National Major Entrepreneurial Talent Program and an academician of the Russian Academy of Natural Sciences, is a high-tech enterprise integrating the innovation, research and development, production, and sales of medical devices. The company is committed to providing innovative quality solutions for intravascular implant and interventional products. In 2017, Innomed was recognized as a National High-Tech Enterprise, and in 2019, it was named one of the top ten medical device solution providers in the Asia-Pacific region by Outlook Medtech.

Currently, Innomed has established a presence in three key segments: peripheral vascular, cardiac valves, and high-value consumables primarily focused on guidewires. In the peripheral vascular segment, Innomed offers products such as iliac vein stents, femoropopliteal artery stents, covered stents, and thrombectomy systems. In the cardiac valve segment, it provides mitral valve repair and tricuspid valve repair solutions. In the guidewire segment, multiple products including angiographic guidewires and guiding guidewires have been launched, with more innovative guidewires under development. Additionally, several of the company’s products have received U.S. FDA 510(k) clearance and EU CE certification, and are now exported to over 20 countries worldwide.

Zenith Vascular, founded in 2018, is a modern technology-based medical device enterprise integrating research and development, production, and sales, dedicated to becoming an innovative solutions provider for vascular diseases.

Over the past five years, Zenith Vascular has developed a series of "innovative and high-quality" vascular intervention products based on clinical pain points and needs in the field of pan-vascular diseases. It has currently obtained 11 product registrations, forming a "comprehensive suction, complete pathway, innovation-supported" AIS one-stop innovative solution advantage. By the end of 2023, it will have cumulatively obtained 15 product registrations, officially starting overseas market promotion. Meanwhile, in the field of carotid artery and intracranial stenosis treatment, Zenith Vascular has completed the R&D and clinical stages for several internationally innovative implantable products.

"VCBeat New Product Review," is a live broadcast column under "VCBeat" that supports the release of innovative medical products. The column's mission is: to assist in the milestone release of every medical innovation product.

Scan the QR code below to contact the assistant and schedule a live broadcast.

(If already added, please ask the assistant proactively.)